Blood derived extracellular vesicles in patients with glioblastoma: preliminary experience from a monoinstitutional series
Although based on a limited number of patients, our methodological study highlights the need for a universal analysis method to compare data from large patient populations in order to use EVs as a biomarker for the diagnosis of recurrence by liquid biopsy, especially in GB, a tumor known for its heterogeneity.
Authors
- Giorgio Carrabba (ORCID: https://orcid.org/0000-0002-0170-0653)
- Francesca Raimondo (ORCID: https://orcid.org/0000-0003-3927-7456)
- Martina Giambra (ORCID: https://orcid.org/0000-0002-4980-8743)
- Francesca Graziano (ORCID: https://orcid.org/0000-0003-1825-3527)
- Andrea N. Cimino (ORCID: https://orcid.org/0000-0002-7920-5943)
- Angela Bentivegna (ORCID: https://orcid.org/0000-0001-7535-846X)
- Carlo Giussani (ORCID: https://orcid.org/0000-0002-9033-2927)
- Alberto Ramponi (ORCID: https://orcid.org/0009-0005-2122-7241)
- Martina Ghizzi
- Marialuisa Lavitrano
- Gianpaolo Basso
Institutions
- Azienda Ospedaliera San Gerardo (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Milano-Bicocca (IT)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1007/s12094-026-04223-w
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00